|
Delayed
Bombay S.E.
00:55:13 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 70.00 INR | -0.57% |
|
-0.14% | -12.77% |
| Market Cap | 2.07B 21.9M 19.55M 18.17M 16.53M 31.09M 31.65M 218M 85.39M 1.08B 82.19M 80.45M 3.46B | P/E 2025 |
-28.6x | P/E 2026 | 4.45x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 22.1M 19.72M 18.33M 16.67M 31.37M 31.94M 220M 86.15M 1.09B 82.92M 81.16M 3.49B | EV / Sales 2025 |
3.93x | EV / Sales 2026 | 1.3x |
| Free-Float |
45.16% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| BROOKS | Delayed | |
Bombay S.E.
| BROOKS | Delayed |
| 1 day | -0.57% | ||
| 1 week | -0.14% | ||
| Current month | +26.13% | ||
| 1 month | +14.40% | ||
| 3 months | +0.14% | ||
| Current year | -12.77% |
| 1 week | 63.04 |  | 73.47 |
| 1 month | 53 | | 75.79 |
| Current year | 36.9 | | 82.3 |
| 1 year | 36.9 | | 131 |
| 3 years | 36.9 | | 202.8 |
| 5 years | 36.9 | | 202.8 |
| 10 years | 14.05 | | 202.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Mahajan
CEO | Chief Executive Officer | 58 | 2002-01-22 |
Prashant Rathi
CEO | Chief Executive Officer | - | 2026-05-31 |
Atul Ranchal
PSD | President | 58 | 2023-08-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2022-11-22 | |
| Director/Board Member | 62 | 2010-09-09 | |
| Director/Board Member | - | 2023-08-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.57% | -0.14% | - | - | 21.9M | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,116B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 610B | |
| +0.59% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 358B | |
| +2.37% | +7.66% | +33.65% | +48.87% | 366B | |
| +2.64% | +6.95% | +21.01% | +43.85% | 288B | |
| +3.24% | +6.78% | +0.43% | +15.71% | 261B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 235B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 195B | |
| Average | +1.44% | +5.27% | +35.10% | +62.44% | 436.64B | |
| Weighted average by Cap. | +1.77% | +4.93% | +38.57% | +71.82% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 826M 8.72M 7.78M 7.23M 6.58M 12.37M 12.6M 86.86M 33.99M 431M 32.71M 32.02M 1.38B | 857M 9.05M 8.08M 7.51M 6.83M 12.85M 13.08M 90.21M 35.29M 447M 33.97M 33.25M 1.43B |
| Net income | -99.67M -1.05M -939K -873K -794K -1.49M -1.52M -10.49M -4.1M -52M -3.95M -3.87M -166M | 246M 2.6M 2.32M 2.15M 1.96M 3.68M 3.75M 25.87M 10.12M 128M 9.74M 9.53M 410M |
| Net Debt | 75.39M 796K 711K 660K 601K 1.13M 1.15M 7.93M 3.1M 39.34M 2.99M 2.92M 126M | 18.44M 195K 174K 161K 147K 276K 281K 1.94M 759K 9.62M 731K 715K 30.78M |
Employees
347
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | ₹70.00 | -0.57% | 713 |
| 26-10-15 | ₹70.40 | +2.40% | 21,937 |
| 26-10-14 | ₹68.75 | +6.28% | 11,798 |
| 26-10-13 | ₹64.69 | -1.51% | 14,268 |
| 26-10-12 | ₹65.68 | -6.31% | 8,273 |
- Stock Market
- Stocks
- BROOKS Stock
- BROOKS Stock
Select your edition
All financial news and data tailored to specific country editions
